Comparison of two systems for nafamostat mesilate monitoring: Hemochron^|^reg; 401 and Hemochron^|^reg; Jr. Signature+

Kenji Uehara(Hiroshima City Asa Citizens Hospital), Keiichi Tada, Masakazu Yamaoka(Himeji Red Cross Hospital), Junichi Sugiyama(Lion Corporation (Japan)), Makoto Takatori
Journal of the Japanese Society of Intensive Care Medicine
January 1, 2014
Cited by 1


Related Papers